SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 222 filers reported holding SEATTLE GENETICS INC in Q2 2015. The put-call ratio across all filers is 1.01 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $768,000 | -90.6% | 3,927 | -91.8% | 0.00% | -89.7% |
| Q2 2020 | $8,180,000 | +1666.7% | 48,139 | +662.1% | 0.04% | +1200.0% |
| Q1 2019 | $463,000 | +29.3% | 6,317 | 0.0% | 0.00% | +50.0% |
| Q4 2018 | $358,000 | -94.1% | 6,317 | -91.9% | 0.00% | -93.8% |
| Q3 2018 | $6,027,000 | +36.0% | 78,146 | +17.1% | 0.03% | +28.0% |
| Q2 2018 | $4,431,000 | +1141.2% | 66,736 | +916.5% | 0.02% | +1150.0% |
| Q3 2017 | $357,000 | +4.1% | 6,565 | -0.9% | 0.00% | 0.0% |
| Q2 2017 | $343,000 | -87.6% | 6,627 | -87.1% | 0.00% | -91.3% |
| Q3 2016 | $2,764,000 | +386.6% | 51,181 | +218.8% | 0.02% | +360.0% |
| Q1 2015 | $568,000 | -55.9% | 16,056 | -60.0% | 0.01% | -58.3% |
| Q4 2014 | $1,289,000 | -40.9% | 40,131 | -16.2% | 0.01% | -50.0% |
| Q1 2014 | $2,182,000 | – | 47,896 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 51,049,760 | $3,738,884,000 | 23.93% |
| Lagoda Investment Management, L.P. | 76,873 | $5,630,000 | 7.16% |
| Matrix Capital Management Company, LP | 3,141,852 | $230,109,000 | 6.14% |
| DOMINI IMPACT INVESTMENTS LLC | 3,120 | $229,000 | 3.51% |
| Opus Point Partners Management, LLC | 17,832 | $1,306,000 | 1.77% |
| Capital International Sarl | 188,200 | $13,784,000 | 1.72% |
| EMORY UNIVERSITY | 33,368 | $2,444,000 | 1.72% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 60,900 | $4,460,000 | 1.65% |
| CAPITAL GUARDIAN TRUST CO | 1,358,254 | $99,415,000 | 1.32% |
| Rhenman & Partners Asset Management AB | 150,598 | $11,030,000 | 1.29% |